[Preventive Chemotherapy for Residual Liver After Resection of Hepatic Metastasis from Colorectal Cancer]
Overview
Authors
Affiliations
We compared 12 cases treated with intra-arterial chemotherapy (group A), with 15 cases only undergoing the usual hepatectomy (June 1991-February 1995). Six cases in group A were H1, 4 were H2, and 2 were H3; 12 cases in group B were H1, and 3 were H2. In both groups, primary lesions were removed. All cases received high-dose intermittent 5-FU infusion (WHF) at 1,000 mg/m2 via a reservoir for 5 hours a week at the outpatient clinic. Cumulative survival rates for 1 and 3 years are 100% and 68.6%, respectively, in group A, and 58.7% and 25.2% in group B, which indicates the treatment outcome in group A was significantly better. Recurrence in residual liver was not found in group A except for one case whose tumor was unremoved, but it was found in 8 cases (53.3%) in group B up to this writing. CEA value after resection in group A was within the normal range except for one case with a local recurrence. It seems that intra-arterial 5-FU infusion chemotherapy for residual liver after resection of hepatic metastasis from colorectal cancer has a preventive effect on residual liver, and the improvement of the cumulative survival rate can be expected.
Cryotherapy for liver metastases.
Bala M, Riemsma R, Wolff R, Pedziwiatr M, Mitus J, Storman D Cochrane Database Syst Rev. 2019; 7:CD009058.
PMID: 31291464 PMC: 6620095. DOI: 10.1002/14651858.CD009058.pub3.
Hepatic resection for metastatic tumors from gastric cancer.
Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H Ann Surg. 2001; 235(1):86-91.
PMID: 11753046 PMC: 1422399. DOI: 10.1097/00000658-200201000-00011.